Medicine · shortage history
Mesalazine
Notified short 2 times on record since 2022 — a recurring shortage spanning 2.2 years. Every entry links to its source; grouping is by medicine name (dm+d coding will refine it).
Most recently declared short 25 Apr 2024. We record when a shortage is declared, not when stock returns — the source doesn't publish that, so this is the shortage history, not live availability. Check with your pharmacy for today's stock.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 25 Apr 2024 | Medicine Supply Notification: Mesalazine (Asacol® ) 400mg MR gastro-resistant tablets | Supply notification | Tier 2 | MSN/2024/048 |
| 10 Feb 2022 | Medicine Supply Notification: Mesalazine (Asacol® ) 400mg and 800mg MR gastro-resistant tablets | Supply notification | Tier 2 | MSN/2022/007 |
An update that shares a reference counts as one episode, so this list can show more rows than the count above. Grouped by the medicine named in each notice's title. Until dm+d coding lands, brand and generic names (and combination products) may sit under separate or first-ingredient entries — see methodology. Not an official NHS or DHSC service.